2016 Cancer Preceptorship for General Practitioners2020-08-11T08:05:20+10:00

The Cancer Care Department of the Royal Brisbane and Women’s Hospital is the largest Cancer service in Queensland, encompassing Haematology, Bone Marrow Transplant, Medical Oncology, Radiation Oncology and Queensland Haemophilia Centre.

Haematology

Spotlight on the Haematology Chair

A/Professor Glen Kennedy, Executive Director, Cancer Care, RBWH

A/Prof Kennedy is the Acting Executive Director of Cancer Care Services at the Royal Brisbane and Women’s Hospital and Metro North Health Service District. He graduated with honours at the University of Queensland in 1993, and subsequently undertook haematology training in Queensland and Victoria.  He has an active interest in education and training, as well as service planning and development and clinical research in transplant and malignant haematology. He has published >70 articles to date, and is the author / primary investigator of several local investigator-initial studies in Queensland.

Dr Jason Butler, Senior Haematologist, RBWH

Dr Jason Butler is a Clinical Haematologist with a Senior Staff Specialist appointment at the Royal Brisbane and Women’s Hospital, Nambour General Hospital, and as a Visiting Medical Officer at Icon Cancer Care.

He completed his dual training in Clinical and Laboratory Haematology in 2004 following a research posting at the Queensland Institute of Medical Research investigating the role of bcl-2 in primary resistance in chronic myeloid leukaemia. Following a fellowship year at the Bone Marrow Transplant Unit, Royal Brisbane and Women’s Hospital, he has since been a Staff Specialist with that unit. In addition, he has provided outreach clinic support to the Nambour General Hospital, and has a small private practice with Icon Cancer Care. Dr Butler also completed a Masters in Medical Science (Clinical Epidemiology), to assist with design and development of investigator-initiator research studies.

His major clinical interests are all aspects of malignant haematology, particularly in leukaemia, lymphoma, and myeloma, as well as autologous and allogeneic stem cell transplantation. Other roles include extensive educational support and clinical presentations for patients and health professionals, and advocacy roles as a board member for Lymphoma Australia.

Dr Cameron Curley, Senior Haematologist, RBWH

Dr Cameron Curley is a clinical haematologist and staff specialist in the department of Haematology and Bone Marrow Transplantation at the RBWH. He graduated from UQ in 1999 and completed training in Haematology at the RBWH and Princess Alexandra Hospitals in 2010 before taking up an appointment as a clinical haematologist at the RBWH. He provides outreach haematology services to Rockhampton and is a visiting medical officer at the Mater Private Hospital, Brisbane and Springfield. He has experience in managing all aspects of haematological malignancy with specific interests in the areas of acute leukaemia and allogeneic stem cell transplantation. He is a member of the National Immunoglobulin Governance Advisory Committee (NIGAC) and the chair of the Specialist working group for Haematology, providing guidance in the optimal use of immunoglobulin therapy.

Dr Kirk Morris, A/Deputy Director, Clinical Haematologist and Bone Marrow Transplant, RBWH

Kirk is Acting Director of Clinical Haematology and Bone Marrow Transplantation at Royal Brisbane and Women’s Hospital. He graduated from the University of Queensland in 1996 and completed haematology training at the Royal Brisbane and Princess Alexandra Hospitals in 2006. He has a broad experience in all aspects of haemato-oncology with specific interest in novel targeted therapies, the management of adolescent and young adult patients with haematologic malignancies, provision of clinical outreach services to regional Queensland, and the development of computer systems to assist the daily practice of busy clinicians. He is the primary education supervisor for haematology trainees at the RBWH.

Medical Oncology

Spotlight on the Medical Oncology Chair

Dr David Wyld, Director of Medical Oncology, RBWH

Associate Professor Wyld is the Director of Medical Oncology at the RBWH. He completed his oncology training in Brisbane, followed by a fellowship in the United Kingdom, before returned to take up a position at RBWH. He has also provided outreach services to Rockhampton for many years. He has a strong clinical interest in gastrointestinal and neuroendocrine tumours and clinical trials, a specific research interest in neuroendocrine tumours and qualitative patient focused research, and an ongoing involvement in education and training. He is also actively involved in broader cancer services planning and development, including being a current member of the State-wide Cancer Clinical Network executive committee.

Dr Matthew Burge, Senior Medical Oncologist, RBWH

Dr Matt Burge is a medical oncologist with a strong interest in gastrointestinal malignancies. He trained as a medical oncologist in Brisbane before undertaking a fellowship in the UK in gastrointestinal cancer. He returned to Brisbane in 2006 and is currently staff specialist at the Royal Brisbane and Womens Hospital, the Prince Charles Hospital and Rockhampton Base Hospital. He is also a visiting oncologist at the Mater Hospital in Rockhampton.

Dr Burge has a broad range of experience in most solid tumour types but has a particular interest in gastrointestinal malignancies. He is involved in a number of clinical trials at the Royal Brisbane Hospital across a range of malignancies. He has also been involved in clinical trials addressing important questions in the management of early breast cancer, metastatic melanoma, ovarian cancer, endometrial cancer, and head and neck cancer in addition to the gastrointestinal malignancies.

Dr David Wyld, Director of Medical Oncology, RBWH and Annette Cubitt, Medical Oncology Clinical Trial Manager, RBWH

Annette Cubitt

30 years with Qld Health primarily Oncology and Palliative Care

Established the Palliative Care/Chemotherapy Unit at the Rockhampton Hospital in the early 1990’s. Last 16 years managing and developing the Medical Oncology Clinical Trials Unit.

Grad Cert in Clinical Trials Management  2004

International  Certification

Association of Clinical Research Professionals

Accredited Certified Clinical Research Coordinator  since 2008

Dr Darshit Thaker, Senior Medical Oncologist/Palliative Care Physician

Dr Darshit Thaker is a Medical Oncologist and Palliative Medicine Physician. He has experience working with Queensland Health; Redcliffe Hospital, Royal Brisbane Hospital and Hervey Bay Hospital.

Specialising in managing all solid tumour types, and with special interest in gastrointestinal, colorectal and breast cancers, Darshit provides effective and personalised care to his patients during their journey from diagnosis to active management to palliation.

He completed his oncology training in RBWH in 2012 and won the prestigious Unicorn Foundation Award to expand his knowledge in neuroendocrine tumours. He did extensive research on Teleoncology, which took him to national and international conferences for oral and poster presentations. He also presented his paper on Palliative Prognostic index at ESMO ASIA 2015. He has multiple publications in field of Oncology and Palliative Care in various peer-reviewed journals.

Darshit has maintained an active interest in teaching and clinical research as well. He is member of AGITG, ASCO, ESMO, MOGA, ANZPM and IAP. He is an accredited supervisor for advanced trainees of RACP, examiner for fellowship exams and Senior Lecturer at University of QLD.

Dr Melissa Eastgate, Deputy Director, Medical Oncology, RBWH

Dr Melissa Eastgate, MBBS, FRACP, Senior Lecturer UQ

Dr Melissa Eastgate is the Deputy Director of Medical Oncology at the RBWH.  Melissa has worked at the RBWH as a medical oncologist since 2004, with her main clinical interests being melanoma and gastrointestinal cancers, in which areas she is an active clinical trial researcher.

Dr Eastgate is also involved in registrar teaching and is a current member and previous chair of the Medical oncology training committee of south east Qld.  She has a strong interest in enabling access to care for patients, having provided outreach services to Bundaberg for 9 years, and is currently setting up an oncology service for patients in Longreach.

Professor Jane Turner, Professor of Psychiatry, University of Queensland

Jane Turner is has worked for 25 years as a consultation-liaison psychiatrist in oncology at Royal Brisbane and Women’s Hospital. She has been extensively involved in the development and implementation of clinical practice guidelines, and communication skills training. Her research and clinical interests focus on the emotional impact of advanced cancer, especially on families, and the development of innovative models of psychosocial care in oncology. She is currently leading a trial of a nurse-delivered survivorship intervention for patients who have completed treatment for head and neck cancer, and is investigator in a multi-site trial of a manual-based intervention for patients with clinically-significant fear of cancer recurrence.

Dr Aneta Suder

Dr Aneta Suder finished medical school at Otago University, Dunedin, New Zealand and spent her junior Doctor years between Wellington, Sydney and London. She completed her specialist training in medical oncology in Auckland, New Zealand and was awarded the Rotary scholarship in translational research. She went onto complete a fellowship at the prestigious Guys hospital and Kings College in urological oncology with a focus on prostate cancer and early drug
development whilst working on numerous phase one clinical trials. She returned to Australia at the end of 2013 and was appointed at the RBWH in 2014 as a consultant staff specialist as well as senior lecturer at UQ. She has written numerous peer reviewed articles, poster presentations and had been an invited speaker at local meetings on prostate cancer. Her current research interests are centred on localised novel therapies as well as sequencing on current therapies for metastatic prostate cancer.

Dr Gary Pratt, Medical Oncologist, RBWH

Gary Pratt is a Radiation Oncologist at RBWH, as well as  visiting PCH ,Redcliffe and Rockhampton Base Hospitals. He has had a long interest and involvement in medical education and is currently Director of the Qld Training Network in Radiation Oncology.

His clinical interests include lymphoma, thoracic, breast and genitourinary sites.

When not at work he likes mucking about in boats anywhere on the water.

Radiation Oncology

Spotlight on the Radiation Oncology Chair

Chair Dr Graeme Dickie, Director of Radiation Oncology, RBWH

Dr Graeme Dickie is the Director of Radiation oncology at RBWH. Medical specialist qualifications include FRACP, FRANZCR, MBA as well as Associate Professor of the University of Queensland. He has been actively involved in research and has been
published extensively for his work in Radiation oncology. He maintains a special interest in head and neck, thyroid, brachytherapy and gastrointestinal cancer.

Dr Gary Pratt, Deputy Director, Radiation Oncology, RBWH

Gary Pratt is a Radiation Oncologist at RBWH, as well as  visiting PCH ,Redcliffe and Rockhampton Base Hospitals. He has had a long interest and involvement in medical education and is currently Director of the Qld Training Network in Radiation Oncology.

His clinical interests include lymphoma, thoracic, breast and genitourinary sites.

When not at work he likes mucking about in boats anywhere on the water.

Gallery

Contact Us

Elaine Chilcott
Email: Med_Onc_Secretary@health.qld.gov.au
Phone: (07) 3646 7983